Report Categories
View AllRecent Articles
View All
Why Crescent Bio CBIO financial health is stronger than most think Near Highs 20260505
ASIC Ategrity delivers 224 percent Q1 2026 EPS beat shares edge higher on upbeat investor reaction
CISS C3is reports widerthanexpected Q3 loss of 058 per share shares fall 2 on elevated costs
How AN2 Thera ANTX performance reflects its true potential Grinds Lower 20260508